These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 38919636)

  • 21. Psilocybin and Obsessive Compulsive Disorder.
    Wilcox JA
    J Psychoactive Drugs; 2014; 46(5):393-5. PubMed ID: 25364991
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Therapeutic Potentials of Ketamine and Esketamine in Obsessive-Compulsive Disorder (OCD), Substance Use Disorders (SUD) and Eating Disorders (ED): A Review of the Current Literature.
    Martinotti G; Chiappini S; Pettorruso M; Mosca A; Miuli A; Di Carlo F; D'Andrea G; Collevecchio R; Di Muzio I; Sensi SL; Di Giannantonio M
    Brain Sci; 2021 Jun; 11(7):. PubMed ID: 34199023
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Classical Psychedelics as Therapeutics in Psychiatry - Current Clinical Evidence and Potential Therapeutic Mechanisms in Substance Use and Mood Disorders.
    Mertens LJ; Preller KH
    Pharmacopsychiatry; 2021 Jul; 54(4):176-190. PubMed ID: 33472250
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Current Understanding on Psilocybin for Major Depressive Disorder: A Review Focusing on Clinical Trials.
    Wang SM; Kim S; Choi WS; Lim HK; Woo YS; Pae CU; Bahk WM
    Clin Psychopharmacol Neurosci; 2024 May; 22(2):222-231. PubMed ID: 38627070
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Psilocybin-assisted psychotherapy for treatment resistant depression: A randomized clinical trial evaluating repeated doses of psilocybin.
    Rosenblat JD; Meshkat S; Doyle Z; Kaczmarek E; Brudner RM; Kratiuk K; Mansur RB; Schulz-Quach C; Sethi R; Abate A; Ali S; Bawks J; Blainey MG; Brietzke E; Cronin V; Danilewitz J; Dhawan S; Di Fonzo A; Di Fonzo M; Drzadzewski P; Dunlop W; Fiszter H; Gomes FA; Grewal S; Leon-Carlyle M; McCallum M; Mofidi N; Offman H; Riva-Cambrin J; Schmidt J; Smolkin M; Quinn JM; Zumrova A; Marlborough M; McIntyre RS
    Med; 2024 Mar; 5(3):190-200.e5. PubMed ID: 38359838
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Single-dose psilocybin for treatment-resistant obsessive-compulsive disorder: A case report.
    Kelmendi B; Kichuk SA; DePalmer G; Maloney G; Ching THW; Belser A; Pittenger C
    Heliyon; 2022 Dec; 8(12):e12135. PubMed ID: 36536916
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sub-acute effects of psilocybin on EEG correlates of neural plasticity in major depression: Relationship to symptoms.
    Skosnik PD; Sloshower J; Safi-Aghdam H; Pathania S; Syed S; Pittman B; D'Souza DC
    J Psychopharmacol; 2023 Jul; 37(7):687-697. PubMed ID: 37392016
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Psychedelic Psychiatry and the Consult-Liaison Psychiatrist: A Primer.
    Barnett BS; Greer GR
    J Acad Consult Liaison Psychiatry; 2021; 62(4):460-471. PubMed ID: 34210406
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Psilocybin compared with escitalopram for depression].
    Strous JFM
    Ned Tijdschr Geneeskd; 2022 Jan; 166():. PubMed ID: 35138714
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term Amelioration of OCD Symptoms in a Patient with Chronic Consumption of Psilocybin-containing Mushrooms.
    Lugo-Radillo A; Cortes-Lopez JL
    J Psychoactive Drugs; 2021; 53(2):146-148. PubMed ID: 33225874
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Are psychedelics fast acting antidepressant agents?].
    Gründer G; Brand M; Kärtner L; Scharf D; Schmitz C; Spangemacher M; Mertens LJ
    Nervenarzt; 2022 Mar; 93(3):254-262. PubMed ID: 35103814
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Classic Psychedelics in Addiction Treatment: The Case for Psilocybin in Tobacco Smoking Cessation.
    Johnson MW
    Curr Top Behav Neurosci; 2022; 56():213-227. PubMed ID: 35704271
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder: A Randomized Clinical Trial.
    Davis AK; Barrett FS; May DG; Cosimano MP; Sepeda ND; Johnson MW; Finan PH; Griffiths RR
    JAMA Psychiatry; 2021 May; 78(5):481-489. PubMed ID: 33146667
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Psilocybin-assisted therapy for depression: A systematic review and meta-analysis.
    Haikazian S; Chen-Li DCJ; Johnson DE; Fancy F; Levinta A; Husain MI; Mansur RB; McIntyre RS; Rosenblat JD
    Psychiatry Res; 2023 Nov; 329():115531. PubMed ID: 37844352
    [TBL] [Abstract][Full Text] [Related]  

  • 35. From psychiatry to neurology: Psychedelics as prospective therapeutics for neurodegenerative disorders.
    Kozlowska U; Nichols C; Wiatr K; Figiel M
    J Neurochem; 2022 Jul; 162(1):89-108. PubMed ID: 34519052
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Psychedelic science in post-COVID-19 psychiatry.
    Kelly JR; Crockett MT; Alexander L; Haran M; Baker A; Burke L; Brennan C; O'Keane V
    Ir J Psychol Med; 2021 Jun; 38(2):93-98. PubMed ID: 32811575
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Beyond Psilocybin: Reviewing the Therapeutic Potential of Other Serotonergic Psychedelics in Mental and Substance Use Disorders.
    Wong S; Yu AY; Fabiano N; Finkelstein O; Pasricha A; Jones BDM; Rosenblat JD; Blumberger DM; Mulsant BH; Husain MI
    J Psychoactive Drugs; 2024; 56(4):513-529. PubMed ID: 37615379
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of Psilocybin-Assisted Therapy in Medicine: A Narrative Review.
    Ziff S; Stern B; Lewis G; Majeed M; Gorantla VR
    Cureus; 2022 Feb; 14(2):e21944. PubMed ID: 35273885
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nature-themed video intervention may improve cardiovascular safety of psilocybin-assisted therapy for alcohol use disorder.
    Heinzerling KG; Sergi K; Linton M; Rich R; Youssef B; Bentancourt I; Bramen J; Siddarth P; Schwartzberg L; Kelly DF
    Front Psychiatry; 2023; 14():1215972. PubMed ID: 37795513
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Psilocybin-assisted group therapy in patients with cancer diagnosed with a major depressive disorder.
    Agrawal M; Richards W; Beaussant Y; Shnayder S; Ameli R; Roddy K; Stevens N; Richards B; Schor N; Honstein H; Jenkins B; Bates M; Thambi P
    Cancer; 2024 Apr; 130(7):1137-1146. PubMed ID: 38105655
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.